Search Results
246 items found for "G protein"
- Ep 01 with Dr. Paul Insel
Alfred Gillman , co-recipient of the 1994 Nobel Prize in Physiology or Medicine for their discovery of G-proteins
- Ep 99 with Yamina Berchihce
GPCR, an ecosystem designed to bring together stakeholders interested in using G-Protein Coupled Receptors
- Ep 123 with Dr. Lukas Grätz
multiple areas of GPCR research such as sequence alignments, generic numbering systems, structure data, G protein and arrestin coupling and more.
- Ep 111 with Chloe Hicks
involved in the activation of Atypical Chemokine Receptor 3 (ACKR3), a receptor which does not couple to G protein and has been shown to maintain its activation in the absence of β-arrestin.
- Ep 157 with Dr. Nagarajan Vaidehi
Following her postdoctoral studies on protein dynamics simulation methods at University of Southern California contributions in developing constrained molecular dynamics simulation methods with emphasis on application to G-protein
- Developing a PROTAC to Degrade the Constitutively Active Onco-GPCR in Uveal Melanoma
Thomas Sakmar’s laboratory at Rockefeller University, where she studies the signaling and degradation of G protein-coupled receptors. understand the signaling and degradation of GPCRs in disease states to help test the feasibility of using protein-targeted
- Coronavirus Porcine Epidemic Diarrhea Virus Utilizes Chemokine Interleukin-8 to Facilitate Viral Replication by Regulating Ca2+ Flux
Finally, we identified that G protein-coupled receptor (GPCR)-phospholipase C (PLC)-inositol trisphosphate G protein-coupled receptor (GPCR)-phospholipase C (PLC)-inositol trisphosphate receptor (IP3R)-SOC signaling
- Ep 108 with Dr. Kenneth A. Jacobson
He adapts interdisciplinary approaches (synthesis, modeling, pharmacology) to study G protein-coupled
- Emerging GPCR targets for AUD: Insights from preclinical studies
Emerging GPCR targets for AUD: Insights from preclinical studies Published date July 5, 2024 Abstract "G protein-coupled receptors (GPCRs) are the largest group of membrane receptors in the central nervous system and one of the key proteins for signal transduction between cells.
- Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML
in Oncology and Immunology Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF mitoxantrone in untreated AML Published date September 12, 2023 Abstract "CC chemokine receptor-3 (hCCR3), a G protein-coupled receptor (GPCR) expressed predominantly on eosinophils, is an important drug target. Rodríguez-Arbolí , Megan Othus , Kelsey-Leigh A Garcia , Mary-Elizabeth M Percival , Ryan D Cassaday , Vivian G
- Itaconate in host inflammation and defense
This metabolite binds to and regulates the function of diverse proteins intracellularly to influence response, epigenetic modification, and gene expression and to signal extracellularly through binding the G protein-coupled receptor (GPCR). Administration of ITA protects against inflammatory diseases and blockade of ITA production enhances In this article, we review ITA metabolism and its regulation, discuss its target proteins and mechanisms
- Ep 63 with Dr. Khaled Abdelrahman
Molecular Medicine and Neuroscience at the University of Ottawa as a Postdoctoral Fellow to explore novel G protein-coupled receptor (GPCR) candidates that can be targeted pharmacologically to slow neurodegeneration
- The power of many: Multilevel targeting of representative chemokine and metabolite GPCRs in personalized cancer therapy
chemokine and metabolite GPCRs in personalized cancer therapy Published date September 12, 2024 Abstract "G protein-coupled receptors (GPCRs) are vital cell surface receptors that govern a myriad of physiological
- Ep 85 with Nicholas Holliday
University of Nottingham in 2006, where he is now Associate Professor, establishing a lab focused on G protein-coupled receptor kinetics, signaling, and trafficking and on using novel imaging techniques,
- Ep 73 with Dr. Aylin Hanyaloglu
Francisco with Professor Mark von Zastrow where she identified novel core cellular machinery critical for G protein-coupled receptor trafficking and signaling.
- Illuminating Functional Selectivity and Allosterism at GPCRs.
molecular pharmacology and his research program focuses on the molecular and cellular mechanisms regulating G protein-coupled receptor (GPCR) responses, a class of receptors involved in many, if not all, physiological He has developed innovative methods for in-cellulo measurement of protein-protein interactions, receptor
- Ep 18 with Dr. Yamina Berchiche
G protein-coupled receptors (GPCRs) mediate a vast variety of critical biological processes and provide How can we best leverage these exciting new techniques in areas such as protein structure prediction,
- Ep 56 with Dr. Adriano Marchese
Philadelphia, PA, for his postdoctoral training in Jeff Benovic’s laboratory studying the regulation of G protein-coupled receptor trafficking and signaling.
- Ep 62 with Dr. Sai Prasad Pydi
Prasad Pydi obtained his Ph.D. from the University of Manitoba – Canada, where he was introduced to G protein-coupled receptors (GPCRs) by Prof.
- Ep 126 with Dr. Françoise Bachelerie
reviewed the standard nomenclature for chemokine receptors that are categorized into a large subgroup of G protein–coupled (GPCR) leukocyte chemotactic receptors (including CXCR4), and a smaller subgroup of atypical
- Session III | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
NTF Release Sensor Approach for Drug Discovery for Human Adhesion GPCRs Stephanie Häfner Abstract "G Protein-coupled receptors (GPCRs) are common drug targets, yet no approved drugs exist for the Adhesion G Protein-coupled receptors (aGPCRs or ADGRs). Salinas "I am currently part of a dynamic research team dedicated to advancing the understanding of G protein-coupled receptors (GPCRs), with a particular focus on the adhesion GPCRs (aGPCRs) family.
- Ep 143 with Dr Davide Calebiro
and Systems Research (IMSR) of the University of Birmingham and Co-Director of the Centre of Membrane Proteins biologists, chemists, physicists, engineers and computer scientists focusing on the basic mechanisms of G protein-coupled receptor (GPCR) signalling and their alterations in endocrine, metabolic and cardiovascular also at intracellular sites and that these receptors interact among themselves and with other membrane proteins
- Student Flash Presentations | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
protein coupled receptor B1 (ADGRB1/BAI1) generated from an alternative promoter in intron 17 Rashed Recent studies implicate the dysregulation of adhesion G-Protein coupled receptors (GPCRs) in GBM development Protein-coupled receptors (aGPCR) have been shown to play a crucial role in the perception of mechanical Rashed Rezwan Parag Abstract "Brain-specific angiogenesis inhibitor 1 (BAI1) belongs to the adhesion G-protein-coupled protein-coupled receptor B1) gene.
- Noval insights and therapeutic strategies for tumor-induced kidney pathologies
Xu et al. identified the mammalian neurokinin 3 receptor (TACR3), a homolog of the G protein-coupled
- Chemoattractant receptor signaling in humoral immunity
responses depends on orchestrated migration of B cells within lymphoid organs, which is governed by G protein-coupled receptors (GPCRs) responding to chemoattractants, represented by chemokines. Our recent study revealed that a protein complex consisting of copper metabolism MURR1 domain-containing
- Expanding role of CXCR2 and therapeutic potential of CXCR2 antagonists in inflammatory diseases and cancers
diseases and cancers Published date March 15, 2023 Abstract " C-X-C motif chemokine receptor 2 (CXCR2) is G protein-coupled receptor (GPCR) and plays important roles in various inflammatory diseases and cancers Hence, we provide an overview containing the discovery history, protein structure, signaling pathways
- Ep 103 with Dr Kathleen Caron
With a special emphasis on G protein coupled receptors and receptor activity modifying proteins in vascular
- A positive Allosteric Modulator of M1 Acetylcholine Receptors Improves Cognitive Deficits in Male and Female Alzheimer’s Mice
Molecular Medicine and Neuroscience at the University of Ottawa as a Postdoctoral Fellow to explore novel G protein-coupled receptor (GPCR) candidates that can be targeted pharmacologically to slow neurodegeneration